The Saint Louis University Division of Hematology and Medical Oncology offers a three-year subspecialty residency that places an emphasis on inpatient and outpatient care, as well as developing the teaching and research skills of our trainees.
This broad-based educational opportunity explores all aspects of solid tumors and malignant and nonmalignant hematologic disorders, as well as bone marrow and peripheral stem cell transplantation.
Entrance into the program requires three years of internal medicine residency training at a United States institution with resulting board eligibility in internal medicine. After completing the program, trainees are board eligible in both hematology and medical oncology by the American Board of Internal Medicine.
Our physicians' interests include breast cancer, lymphomas, leukemias, head and neck tumors, GI malignancies, lung cancer, colon cancer, prostate cancer, sarcomas, melanomas and myeloma. Additional interests include autoimmune diseases, both autologous and allogeneic bone marrow and peripheral stem cell transplantation, as well as thrombotic and bleeding disorders.
Hemostasis and Thrombotic Disorders Program
SLU’s hemostasis and thrombotic disorders program includes the Regional Hemophilia Treatment Center and Coagulation Reference Laboratory.
Our transplant team uses resources such as the National Marrow Donor Program, International Bone Marrow Transplant Registry, and Autologous Blood and Marrow Transplant Registry. Our trainees also have an opportunity to learn management of conditions related to transplantation, such as graft versus host disease and immune system dysfunction.
Best Doctors 2015
Hematology and Medical Oncology Subspecialty Residency Program
Hematology and Medical Oncology Training
First-year trainees practice inpatient care and consult skills, and see patients in the outpatient clinic. During their second year, trainees rotate through subspecialty clinical assignments in disciplines such as radiation oncology, immunopathology, gynecologic oncology, hemostasis laboratory, nuclear medicine, blood banking and cytogenetics. Third-year trainees refine their patient care skills and focus on the research and development of clinical studies.
Trainees are also educated in chemotherapy administration and safety precautions, as well as procedures such as bone marrow biopsy and aspiration, bone marrow harvest, and various laboratory procedures. Throughout their three years, trainees attend many educational lectures and multidisciplinary conferences and regularly give their own presentations. They attend national conferences such as the American Society of Clinical Oncology and American Society of Hematology meetings.
Our subspecialty residents continually have exposure to clinical research studies during their training. Our division is involved with protocols sponsored by the Southwest Oncology Group (SWOG), the National Adjuvant Breast and Bowel Project (NSABP), and with various corporate-sponsored and in-house studies. Trainees are expected to produce abstracts and a manuscript and/or protocol by the end of their third year.
|First||Six months||Hematology and Oncology Inpatient Consult Service|
|First||Six months||Hematology, Oncology and Bone Marrow Transplant Inpatient Floor Service|
|Second||Six months||Subspecialty Clinic Assignments|
|Second||Six months||Hemostasis and Thrombosis Inpatient Consult Service|
|Third||12 months||Clinical or Bench Research|
|First||12 months (one half-day per week)||Outpatient Hematology-Oncology Clinic|
|Second||12 months (one half-day per week)||Outpatient Hematology-Oncology Clinic|
|Third||12 months (three half-days per week)||Outpatient Hematology-Oncology Clinic|